Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28586646 | 0.98 | MEN1 (0.44) | MEN1KMT2APOLBGAANPSR1 | |
| SCHEMBL17694459 | 0.88 | MEN1 (0.43) | MEN1KMT2APOLBGAANPSR1 | |
| SCHEMBL17694457 | 0.86 | MEN1 (0.42) | MEN1KMT2APOLBGAANPSR1 | |
| SCHEMBL24961372 | 0.83 | MEN1 (0.43) | MEN1KMT2A | |
| SCHEMBL19117106 | 0.83 | MEN1 (0.43) | MEN1KMT2A | |
| SCHEMBL10010915 | 0.83 | MEN1 (0.43) | MEN1KMT2A | |
| SCHEMBL10011134 | 0.82 | MEN1 (0.50) | MEN1KMT2A | |
| SCHEMBL10012666 | 0.82 | MEN1 (0.42) | MEN1KMT2A | |
| SCHEMBL10033538 | 0.82 | MEN1 (0.46) | MEN1KMT2A | |
| SCHEMBL20528155 | 0.79 | MEN1 (0.56) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015308-A1 | SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-01-19 | — | — | US | disclosed |
| CN-108586500-B | Zinc coordination complex and method for preparing organic zinc reagent | 慕尼黑路德维希马克西米利安斯大学 | 2021-06-25 | — | — | CN | disclosed |
| CN-103429598-A | Organozinc complexes and methods of making and using the same | UNIV MUENCHEN L MAXIMILIANS | 2013-12-04 | — | — | CN | disclosed |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ADORA2A, ADORA1, PDE2A | MEN1 3926/4885KMT2A 2302/4885POLB 4166/4885 |
| US-20230015308-A1 | SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | WEE1, CBR3, GLRX3 | MEN1 4484/4885KMT2A 3228/4885POLB 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.